Compound Detail
CHEMBL203321
BRINCIDOFOVIR 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL203321 |
| Name | BRINCIDOFOVIR |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WXJFKKQWPMNTIM-VWLOTQADSA-N |
| Therapeutic | ✓ Yes |
| Active Moiety | CHEMBL4594372 |
8
Targets
21
Activities
2
Assay Types
4
PK Parameters
20
Publications
8
Known Names
8
Indications
1
Mechanisms
Molecular Properties
561.7
MW (Da)
5.25
ALogP
9
HBA
3
HBD
146.1
PSA (Ų)
0.10
QED
2
Ro5 Violations
26
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2021 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| DNA polymerase inhibitor | INHIBITOR | DNA polymerase | ✓ | ✓ |
Indications
Smallpox Virus Diseases Adenoviridae Infections Adenoviridae Infections Cytomegalovirus Infections Adenovirus Infections, Human Hemorrhagic Fever, Ebola Liver Diseases
ATC Classification
J05AB17
brincidofovir
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE
Drug Warnings
Black Box Warning
General Warning
Activity Summary
EC50 17 meas. best 9.05
IC50 4 meas. best 6.71
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human betaherpesvirus 5 CHEMBL371 | EC50 | 9.05 | 9.05 | 0.9 | 2 |
| Murid betaherpesvirus 1 CHEMBL613495 | EC50 | 9.05 | 9.05 | 0.9 | 1 |
| Caviid betaherpesvirus 2 CHEMBL614682 | EC50 | 8.4 | 8.4 | 4.0 | 1 |
| Cowpox virus CHEMBL612672 | EC50 | 7.22 | 6.57 | 60.0 | 4 |
| Vaccinia virus CHEMBL613493 | EC50 | 7.1 | 6.5857 | 80.0 | 7 |
| Ectromelia virus Moscow CHEMBL612728 | EC50 | 6.9 | 6.9 | 125.0 | 1 |
| Vaccinia virus CHEMBL613493 | IC50 | 6.71 | 6.615 | 196.0 | 2 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 6.7 | 6.7 | 200.0 | 1 |
| Human adenovirus 5 CHEMBL612237 | IC50 | 6.61 | 6.61 | 245.0 | 1 |
| Cowpox virus CHEMBL612672 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 6.15 | hr | Homo sapiens |
| T1/2 | 32.7 | hr | Homo sapiens |
| T1/2 | 24.0 | hr | Homo sapiens |
| Tmax | 7.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21078944 | 10.1128/aac.00971-10 | Caviid betaherpesvirus 2 | 31 |
| 17724153 | 10.1128/aac.00762-07 | Cowpox virus | 18 |
| 21078944 | 10.1128/aac.00971-10 | Cavia porcellus | 12 |
| 21493074 | 10.1016/j.bmc.2011.03.034 | Liver | 7 |
| 37390509 | 10.1016/j.ejmech.2023.115601 | ADMET | 7 |
| 17846137 | 10.1128/aac.00184-07 | Unchecked | 3 |
| 17724153 | 10.1128/aac.00762-07 | Unchecked | 3 |
| 27559756 | 10.1021/acs.jmedchem.6b00523 | ADMET | 3 |
| 21493074 | 10.1016/j.bmc.2011.03.034 | ADMET | 3 |
| 21493074 | 10.1016/j.bmc.2011.03.034 | Unchecked | 3 |
| 17846137 | 10.1128/aac.00184-07 | Vaccinia virus | 2 |
| 17724153 | 10.1128/aac.00762-07 | Vaccinia virus | 2 |
| 37390509 | 10.1016/j.ejmech.2023.115601 | Vaccinia virus | 2 |
| 17846137 | 10.1128/aac.00184-07 | HFF | 1 |
| 19112024 | 10.1016/j.bmc.2008.11.075 | Cowpox virus | 1 |
| 37390509 | 10.1016/j.ejmech.2023.115601 | Human adenovirus 5 | 1 |
| 17724153 | 10.1128/aac.00762-07 | HFF | 1 |
| 21078944 | 10.1128/aac.00971-10 | ADMET | 1 |
| 16539388 | 10.1021/jm050473m | Vaccinia virus | 1 |
| 16539388 | 10.1021/jm050473m | Murid betaherpesvirus 1 | 1 |
Data from ChEMBL 36 via Core Engine